José Luis
del Pozo León
Consultor Médico
Jordi
Carratalà Fernández
Publicaciones en las que colabora con Jordi Carratalà Fernández (11)
2024
-
How can we optimize the diagnostic and therapeutic approach of pneumonia? Expert opinion-based recommendations
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 8, pp. 442-452
-
Pseudomonas aeruginosa Bloodstream Infections Presenting with Septic Shock in Neutropenic Cancer Patients: Impact of Empirical Antibiotic Therapy
Microorganisms, Vol. 12, Núm. 4
2022
-
Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia
Microorganisms, Vol. 10, Núm. 4
-
Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors
Pathogens, Vol. 11, Núm. 10
-
Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study)
Microbiology Spectrum, Vol. 10, Núm. 3
2021
-
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792
2020
-
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: Protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)
Trials, Vol. 21, Núm. 1
2019
2012
-
Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: A matched case-control study
Clinical Infectious Diseases, Vol. 54, Núm. 3, pp. 355-361